Benvegnù L, Noventa F, Bernardinello E, Pontisso P, Gatta A, Alberti A
Department of Clinical and Experimental Medicine, Clinica Medica 5 degrees, University of Padova, Italy.
Gut. 2001 Jan;48(1):110-5. doi: 10.1136/gut.48.1.110.
Patients with liver cirrhosis are at significant risk of hepatocellular carcinoma (HCC) that may develop as well defined nodular lesions or as more aggressive infiltrating tumours.
To compare prospectively risk factors associated with nodular or infiltrating HCC in cirrhotic patients.
We studied 370 patients with cirrhosis, followed prospectively by periodic ultrasound (US) of the liver, for a mean period of 74.6 (SD 32.4) months to define the incidence and patterns of HCC development. Patients who developed HCC were compared according to tumour pattern using univariate and multivariate analysis.
Sixty one (16.5%) patients developed HCC: HCC was classified as nodular in 49 (80.3%) and infiltrating in 12 (19.7%) according to US and computerised tomography (CT) imaging. The five and 10 year cumulative probabilities were 8.1% (95% confidence interval (CI) 5. 2%-11%) and 25.2% (15.0-35.4%) for nodular HCC and 2.1% (0.5-3.7%) and 6.9% (2.1-11.7%) for infiltrating HCC. Patients with infiltrating HCC were younger than those with nodular HCC (59.5 v 66. 2 years, 95% CI 55.2-63.8 and 64.1-68.3 years; p=0.014). Using multivariate analysis, development of nodular HCC was associated with older age (p=0.0002; relative risk (RR) 3.1; 95% CI 1.6-5.2), longer duration (p=0.09; RR 2.6; 95% CI 1.8-3.4), and more advanced stage (p=0.002; RR 2.5; 95% CI 1.3-4.5) of cirrhosis but not with the aetiology of liver disease. In contrast, development of infiltrating HCC appeared to be unrelated to age or disease duration or stage, while it was associated with hepatitis B virus infection (p=0.07; RR 3.96; 95% CI 1.1-5.2) and with hepatitis B/hepatitis C virus coinfection (p=0.0007; RR 16.9; 95% CI 3.8-36.7).
In liver cirrhosis, we identified two patterns of HCC developing with distinct risk factors. Nodular HCC was related to the cirrhotic process per se independent of aetiological factors and may depend on the proliferative activity within regenerative nodules, while the infiltrating form of HCC was linked to hepatitis B virus infection and may reflect more direct virus induced carcinogenesis.
肝硬化患者患肝细胞癌(HCC)的风险很高,HCC可能发展为边界清晰的结节性病变或侵袭性更强的浸润性肿瘤。
前瞻性比较肝硬化患者发生结节性或浸润性HCC的相关危险因素。
我们研究了370例肝硬化患者,对其肝脏进行前瞻性定期超声(US)检查,平均随访74.6(标准差32.4)个月,以确定HCC发生的发生率和模式。根据肿瘤模式,采用单因素和多因素分析对发生HCC的患者进行比较。
61例(16.5%)患者发生HCC:根据US和计算机断层扫描(CT)成像,49例(80.3%)HCC被分类为结节性,12例(19.7%)为浸润性。结节性HCC的5年和10年累积概率分别为8.1%(95%置信区间(CI)5.2%-11%)和25.2%(15.0-35.4%),浸润性HCC分别为2.1%(0.5-3.7%)和6.9%(2.1-11.7%)。浸润性HCC患者比结节性HCC患者年轻(59.5岁对66.2岁,95%CI 55.2-63.8岁和64.1-68.3岁;p=0.014)。采用多因素分析,结节性HCC的发生与年龄较大(p=0.0002;相对风险(RR)3.1;95%CI 1.6-5.2)、病程较长(p=0.09;RR 2.6;95%CI 1.8-3.4)和肝硬化分期较晚(p=0.002;RR 2.5;95%CI 1.3-4.5)有关,但与肝病病因无关。相比之下,浸润性HCC的发生似乎与年龄、病程或分期无关,而与乙型肝炎病毒感染(p=0.07;RR 3.96;95%CI 1.1-5.2)和乙型肝炎/丙型肝炎病毒合并感染(p=0.0007;RR 16.9;95%CI 3.8-36.7)有关。
在肝硬化中,我们发现了两种具有不同危险因素的HCC发展模式。结节性HCC与肝硬化本身相关,独立于病因因素,可能取决于再生结节内的增殖活性,而浸润性HCC与乙型肝炎病毒感染有关,可能反映了更直接的病毒诱导致癌作用。